Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Immunocore Limited:
We consent to the use of our report incorporated by reference herein.
Our report refers to a change in the method of accounting for leases as of January 1, 2019, due to the adoption of IFRS 16, Leases.
/s/ KPMG LLP
London, United Kingdom
April 12, 2021